Lee Yoon-hee

PB
· tracked since Jan 2026
Calls
4
Win Rate
25.0%
return
-35.6%
Calls 4 2 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 0
Win Rate 25% Long 4 Short 0
Win Rate
7d 33%
30d 67%
90d 50%
Average Return -35.6% Long Return -35.6% Short Return -
Average Return
7d +1.3%
30d +4.8%
90d -9.3%
Visual Insights Log in to see more
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 12
$1189000.00
+8.3%
Samyang Foods benefits from price hikes
Samyang Foods remains fundamentally attractive because price increases can lift earnings and demand for its products is still strong despite the recent share-price correction.
Packaged Foods
Long
Jan 12
$330500.00
-49.9%
HYBE attractive on BTS tour
HYBE is attractive because BTS world-tour schedule disclosure is a near-term catalyst, and the stock has already been consolidating; weakness can be an opportunity.
Gaming & Entertainment
Long
Jan 12
$179300.00
-53.6%
Korean biotech is a buy on dip
Korean biotech is a buy-on-dip opportunity: JPMorgan Healthcare Conference catalysts, KOSDAQ activation policy, and event-driven selloffs create entry points for quality bio names.
Pharma & Biotech
Showing 3 of 4 calls · sorted by mentions

Lee Yoon-hee has 4 trade ideas tracked on Buzzberg across 4 tickers since January 2026. Most covered: 352820.KS, 003230.KS, KOREAN BIOTECH.

Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology